Electrocardiographic changes associated with SGLT2 inhibitors and non-SGLT2 inhibitors: A multi-center retrospective study

Electrocardiographic changes associated with SGLT2 inhibitors and non-SGLT2 inhibitors: A multi-center retrospective study

BackgroundSodium-glucose co-transporter 2 (SGLT2) inhibitors has been shown with cardiovascular benefit in type 2 diabetes mellitus (T2DM) patients. However, its osmotic diuresis still concern physicians who may look for possible electrolyte imbalance. We therefore aimed to investigate electrocardio...

Full description

Bibliographic Details
Main Authors: Victor Chien-Chia Wu, Kai-Pin Chiu, Chun-Li Wang, Chiu-Yi Hsu, Hui-Tzu Tu, Yu-Tung Huang, Chih-Hsiang Chang, Chien-Hao Huang, Chang-Fu Kuo, Shao-Wei Chen, Pao-Hsien Chu, Shang-Hung Chang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
type 2 diabetes mellitus
sodium-glucose co-transporter 2 (SGLT 2) inhibitors
electrocardiogram
QT prolongation
outcome
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.934193/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.934193/full

Similar Items